View in EDS

Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.

Saved in:
Bibliographic Details
Title: Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Authors: Demchuk AM; Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, AB, Canada (A.M.D.)., Yue P; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.)., Zotova E; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.)., Nakamya J; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.)., Xu L; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.)., Milling TJ Jr; Department of Neurology, Seton Dell Medical School Stroke Institute, Austin, TX (T.J.M.)., Ohara T; Department of Neurology, Kyoto Prefectural University of Medicine, Japan (T.O.)., Goldstein JN; Department of Emergency Medicine, Massachusetts General Hospital, Boston (J.N.G.)., Middeldorp S; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef, the Netherlands (S.M.)., Verhamme P; Center for Molecular and Vascular Biology, University of Leuven, Belgium (P.V.)., Lopez-Sendon JL; Department of Cardiology, Hospital Universitario La Paz, IdiPaz, Universidad Autonoma de Madrid, Spain (J.L.L.-S.)., Conley PB; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.)., Curnutte JT; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.)., Eikelboom JW; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.)., Crowther M; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.)., Connolly SJ; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
Corporate Authors: ANNEXA-4 Investigators
Source: Stroke [Stroke] 2021 Jun; Vol. 52 (6), pp. 2096-2105. Date of Electronic Publication: 2021 May 10.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4628 (Electronic) Linking ISSN: 00392499 NLM ISO Abbreviation: Stroke Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33966491
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Demchuk+AM%22">Demchuk AM</searchLink>; Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, AB, Canada (A.M.D.).<br /><searchLink fieldCode="AU" term="%22Yue+P%22">Yue P</searchLink>; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).<br /><searchLink fieldCode="AU" term="%22Zotova+E%22">Zotova E</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).<br /><searchLink fieldCode="AU" term="%22Nakamya+J%22">Nakamya J</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).<br /><searchLink fieldCode="AU" term="%22Xu+L%22">Xu L</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).<br /><searchLink fieldCode="AU" term="%22Milling+TJ+Jr%22">Milling TJ Jr</searchLink>; Department of Neurology, Seton Dell Medical School Stroke Institute, Austin, TX (T.J.M.).<br /><searchLink fieldCode="AU" term="%22Ohara+T%22">Ohara T</searchLink>; Department of Neurology, Kyoto Prefectural University of Medicine, Japan (T.O.).<br /><searchLink fieldCode="AU" term="%22Goldstein+JN%22">Goldstein JN</searchLink>; Department of Emergency Medicine, Massachusetts General Hospital, Boston (J.N.G.).<br /><searchLink fieldCode="AU" term="%22Middeldorp+S%22">Middeldorp S</searchLink>; Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Meibergdreef, the Netherlands (S.M.).<br /><searchLink fieldCode="AU" term="%22Verhamme+P%22">Verhamme P</searchLink>; Center for Molecular and Vascular Biology, University of Leuven, Belgium (P.V.).<br /><searchLink fieldCode="AU" term="%22Lopez-Sendon+JL%22">Lopez-Sendon JL</searchLink>; Department of Cardiology, Hospital Universitario La Paz, IdiPaz, Universidad Autonoma de Madrid, Spain (J.L.L.-S.).<br /><searchLink fieldCode="AU" term="%22Conley+PB%22">Conley PB</searchLink>; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).<br /><searchLink fieldCode="AU" term="%22Curnutte+JT%22">Curnutte JT</searchLink>; Portola Pharmaceuticals, Inc, now Alexion Pharmaceuticals, Inc, South San Francisco, CA (P.Y., P.B.C., J.T.C.).<br /><searchLink fieldCode="AU" term="%22Eikelboom+JW%22">Eikelboom JW</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).<br /><searchLink fieldCode="AU" term="%22Crowther+M%22">Crowther M</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).<br /><searchLink fieldCode="AU" term="%22Connolly+SJ%22">Connolly SJ</searchLink>; Department of Medicine, McMaster University, Hamilton, ON, Canada (E.Z., J.N., L.X., J.W.E., M.C., S.J.C.).
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ANNEXA-4+Investigators%22">ANNEXA-4 Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220235266%22">Stroke</searchLink> [Stroke] 2021 Jun; Vol. 52 (6), pp. 2096-2105. <i>Date of Electronic Publication: </i>2021 May 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0235266 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4628 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200392499%22">00392499 </searchLink><i>NLM ISO Abbreviation: </i>Stroke <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33966491
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1161/STROKEAHA.120.030565
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2096
    Titles:
      – TitleFull: Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Demchuk AM
      – PersonEntity:
          Name:
            NameFull: Yue P
      – PersonEntity:
          Name:
            NameFull: Zotova E
      – PersonEntity:
          Name:
            NameFull: Nakamya J
      – PersonEntity:
          Name:
            NameFull: Xu L
      – PersonEntity:
          Name:
            NameFull: Milling TJ Jr
      – PersonEntity:
          Name:
            NameFull: Ohara T
      – PersonEntity:
          Name:
            NameFull: Goldstein JN
      – PersonEntity:
          Name:
            NameFull: Middeldorp S
      – PersonEntity:
          Name:
            NameFull: Verhamme P
      – PersonEntity:
          Name:
            NameFull: Lopez-Sendon JL
      – PersonEntity:
          Name:
            NameFull: Conley PB
      – PersonEntity:
          Name:
            NameFull: Curnutte JT
      – PersonEntity:
          Name:
            NameFull: Eikelboom JW
      – PersonEntity:
          Name:
            NameFull: Crowther M
      – PersonEntity:
          Name:
            NameFull: Connolly SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2021 Jun
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1524-4628
          Numbering:
            – Type: volume
              Value: 52
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Stroke
              Type: main
ResultId 1